The meniscus is a soft, fibrous cartilage that sits between the femur and tibia. In a healthy knee, it acts as a natural shock absorber, helping distribute force across the joint. When meniscus tissue is damaged or removed, that force is transmitted abnormally, leading to cartilage wear, pain, arthritis, and loss of activities.
Meniscus tears are often treated by trimming or removing the damaged tissue. This can relieve symptoms in the short term, but the loss of meniscus tissue accelerates the process of joint damage and the onset of osteoarthritis (OA), causing pain and making it increasingly difficult for people to remain active over time.
SRF research demonstrates that replacing all or part of a damaged or missing meniscus with allograft (donor) cartilage can help restore its function. Our long-term findings challenge the assumption that age, arthritis, or demanding athletic goals must bring an active life to an end.
Patients once considered outside the traditional limits of transplantation may now have an opportunity to preserve their natural knee and return to high-level activity.
Through our clinical research and leadership of the Meniscus Transplant Study Group, SRF brings together international expertise to advance the science of meniscus transplantation and move discoveries into clinical care.